Obstacles and opportunities in the clinical development of targeted therapeutics.

Dy Grace K, Adjei Alex A

Department of Internal Medicine, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, MN 55905, USA.

Prog Drug Res. 2005;63:19-41. doi: 10.1007/3-7643-7414-4_2.

Abstract

摘要

相似文献

Prog Drug Res. 2005;63:19-41. doi: 10.1007/3-7643-7414-4_2.

Cancer. 2010 Nov 15;116(22):5116-8. doi: 10.1002/cncr.25543.

Nat Rev Clin Oncol. 2009 May;6(5):259-65. doi: 10.1038/nrclinonc.2009.38.

J Med Chem. 2004 Apr 8;47(8):1869-78. doi: 10.1021/jm0305467.

Hematol Oncol Clin North Am. 2001 Aug;15(4):631-55. doi: 10.1016/s0889-8588(05)70240-9.

J Clin Oncol. 1995 May;13(5):1282-3. doi: 10.1200/JCO.1995.13.5.1282.

Science. 2002 Oct 18;298(5593):522-5. doi: 10.1126/science.298.5593.522.

Clin Pharmacol Ther. 2020 Sep;108(3):419-421. doi: 10.1002/cpt.1919. Epub 2020 Jul 8.

Minerva Med. 1999 Jul-Aug;90(7-8):203-4.

Clin Cancer Res. 2004 Jun 1;10(11):3897-907. doi: 10.1158/1078-0432.CCR-03-0786.

Cancer Med. 2018 May;7(5):1766-1773. doi: 10.1002/cam4.1436. Epub 2018 Mar 25.

Curr Cancer Drug Targets. 2009 Mar;9(2):189-201. doi: 10.2174/156800909787580971.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。